Paint for treating benign prostate hyperplasia and its use
A technology for prostatic hyperplasia and coating agent, which is applied in the directions of medical preparations containing active ingredients, pharmaceutical devices, organic active ingredients, etc., can solve problems such as easy to cause infection, achieve no side effects and side effects, easy preparation and use, and curative effect. significant effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Cetyl alcohol 5
[0031] Lanolin 4
[0032] lanolin 4
[0033] white oil 5
[0034] mink oil 2
[0035] 1-n-dodecylazepan-2-one 5
[0036] Glyceryl Tristearate 5
[0037] Siben-60 4
[0038] Tween-60 2
[0039] Glycerin 5
[0040] Hyaluronic Acid 0.5
[0041] Kayson CG 0.05
[0042] Compound 2 0.1
[0043] Compound 9 0.1
[0044] margin is H 2 O, make up to 100.
[0045] Trial effect observation:
[0046] The improvement rate of urinary obstruction was 91%, the effective rate of nocturia frequency improvement was 67%, and the average urine flow rate increased from (4.6±2) ml / s before treatment to (6.5±2.2) ml / s after treatment.
Embodiment 2
[0048] Compound 6 30
[0049] Compound 12 50
[0050] Octadecanoic acid 2
[0051] cetyl alcohol 1
[0052] Anhydrous lanolin 1
[0053] white oil 1
[0054]1-n-dodecylazepan-2-one 3
[0055] Isopropyl myristate 2
[0056] Siben-60 1
[0057] Triethanolamine 1
[0058] Propylene Glycol 2
[0059] Kayson CG 0.05
[0060] margin is H 2 O, make up to 100.
[0061] Trial effect observation:
[0062] The improvement rate of urinary obstruction was 98%, the effective rate of nocturia frequency improvement was 97%, and the average urine flow rate increased from (4.1±2.1) ml / s before treatment to (7.8±2.7) ml / s after treatment.
Embodiment 3
[0064] cetyl alcohol 3
[0065] Lanolin 2
[0066] lanolin 2
[0067] white oil 3
[0068] mink oil 1
[0069] 1-n-dodecylazepan-2-one 3
[0070] Glyceryl Tristearate 3
[0071] Siben-60 2
[0072] Tween-60 1
[0073] Glycerin 3
[0074] Hyaluronic Acid 0.5
[0075] Kayson CG 0.05
[0076] Compound 3 0.1
[0077] Compound 11 15
[0078] Compound 12 35
[0079] margin is H 2 O, make up to 100.
[0080] Trial effect observation:
[0081] The improvement rate of voiding obstruction was 92%, the effective rate of nocturia frequency improvement was 68%, and the average urine flow rate increased from (4.5±2) ml / s before treatment to (6.7±2.2) ml / s after treatment.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com